Merck discontinues development of 2 experimental cancer drugs after trial failures
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.
Related Articles
Advancement in predictive biomarkers for gestational diabetes mellitus diagnosis and related outcomes: a scoping review
Objective Gestational diabetes mellitus (GDM) is a metabolic disorder associated with adverse maternal and neonatal outcomes. While GDM is diagnosed by oral glucose tolerance testing…
SARCOPENIA
El cuerpo humano es esa máquina perfecta, fruto de miles de años de evolución, de estudios y pruebas fallidas…
Pharmacy benefits managers should be worried
Former FTC policy director David Balto says PBMs should be very worried about the new Trump administration and pending congressional action.
The Framework Laptop 16 just got a modular gadget that enables quadruple SSDs
Two with this new module, plus two in the original machine
TSMC’s New Arizona Fab! Apple Will Finally Make Advanced Chips In The U.S.
On 1,100 acres in the Arizona desert north of Phoenix, a newly completed 3.5-million-square foot building is making history as the most advanced chip fabrica…
Medicine Advances Call for Papers AI-Based Quantitative Medical Imaging in Cancer Evolution
Medicine Advances is an open access general medical journal with a focus on new technologies, methods and products in the full life cycle of diseases.
Upadacitinib Sustained Efficacy, Safety Among Patients with Atopic Dermatitis Over 188 Weeks
This interim analysis highlights positive findings from the Measure Up 1 and 2 studies regarding upadacitinib for patients with atopic dermatitis.
The Secrets Inside the Ancient Crystals of Long-Dead Stars
Presolar grains are solid minerals, on the scale of nanometers to micrometers, that crystallized in the gassy outflows and ejecta of stars that existed before…
Kindbody founder Gina Bartasi stepping down as CEO
Kindbody has been exploring a potential sale while simultaneously seeking $10 million in bridge financing to maintain operations.
